Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID O15162 5359 PLSCR1 Lung adenocarcinoma Ubiquitination N K132 O15162 5359 PLSCR1 Pancreatic adenocarcinoma Phosphorylation N T161 P67809 4904 YBX1 NSEP1 YB1 Ovarian serous cystadenocarcinoma Acetylation N K64 P67809 4904 YBX1 NSEP1 YB1 Ovarian serous cystadenocarcinoma Ubiquitination N K64 P67809 4904 YBX1 NSEP1 YB1 Lung squamous cell carcinoma Phosphorylation N Y99 P67809 4904 YBX1 NSEP1 YB1 Lung squamous cell carcinoma Methylation N R101 P67809 4904 YBX1 NSEP1 YB1 Lung squamous cell carcinoma Phosphorylation N S102 P67809 4904 YBX1 NSEP1 YB1 Lung squamous cell carcinoma Phosphorylation N T108 P67809 4904 YBX1 NSEP1 YB1 Stomach adenocarcinoma Ubiquitination N K118 P67809 4904 YBX1 NSEP1 YB1 Colon adenocarcinoma Phosphorylation N S136 P67809 4904 YBX1 NSEP1 YB1 Lung adenocarcinoma Phosphorylation N S136 P67809 4904 YBX1 NSEP1 YB1 Colon adenocarcinoma Ubiquitination N K137 P67809 4904 YBX1 NSEP1 YB1 Lung adenocarcinoma Ubiquitination N K137 P67809 4904 YBX1 NSEP1 YB1 Colon adenocarcinoma Methylation N R142 P67809 4904 YBX1 NSEP1 YB1 Ovarian cancer Phosphorylation N Y145 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R199 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R200 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R204 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R205 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N Y208 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S209 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R239 P67809 4904 YBX1 NSEP1 YB1 Uterine corpus endometrial carcinoma Methylation N R239 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R242 P67809 4904 YBX1 NSEP1 YB1 Uterine corpus endometrial carcinoma Methylation N R242 P67809 4904 YBX1 NSEP1 YB1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R244 P67809 4904 YBX1 NSEP1 YB1 Hepatocellular carcinoma Methylation N R244 P67809 4904 YBX1 NSEP1 YB1 Uterine corpus endometrial carcinoma Methylation N R244 P67809 4904 YBX1 NSEP1 YB1 Stomach adenocarcinoma Phosphorylation N T271 P67809 4904 YBX1 NSEP1 YB1 Head and neck squamous cell carcinoma Methylation N R279 P67809 4904 YBX1 NSEP1 YB1 Stomach adenocarcinoma Methylation N R279 P67809 4904 YBX1 NSEP1 YB1 Head and neck squamous cell carcinoma Methylation N R280 P67809 4904 YBX1 NSEP1 YB1 Stomach adenocarcinoma Methylation N R280 P67809 4904 YBX1 NSEP1 YB1 Head and neck squamous cell carcinoma Phosphorylation N Y281 P67809 4904 YBX1 NSEP1 YB1 Stomach adenocarcinoma Phosphorylation N Y281 P67809 4904 YBX1 NSEP1 YB1 Adrenocortical carcinoma Ubiquitination N K296 P67809 4904 YBX1 NSEP1 YB1 Bladder urothelial carcinoma Ubiquitination N K296 P67809 4904 YBX1 NSEP1 YB1 Skin cutaneous melanoma Acetylation N K304 P67809 4904 YBX1 NSEP1 YB1 Skin cutaneous melanoma Ubiquitination N K304 P67809 4904 YBX1 NSEP1 YB1 Lung adenocarcinoma Phosphorylation N S313 P67809 4904 YBX1 NSEP1 YB1 Pancreatic adenocarcinoma Phosphorylation N S313 P67809 4904 YBX1 NSEP1 YB1 Skin cutaneous melanoma Phosphorylation N S313 P67809 4904 YBX1 NSEP1 YB1 Lung adenocarcinoma Phosphorylation N S314 P67809 4904 YBX1 NSEP1 YB1 Pancreatic adenocarcinoma Phosphorylation N S314 P67809 4904 YBX1 NSEP1 YB1 Skin cutaneous melanoma Phosphorylation N S314 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Kidney renal clear cell carcinoma Phosphorylation N S105 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Phosphorylation N S105 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Kidney renal clear cell carcinoma Phosphorylation N S107 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Phosphorylation N S107 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Phosphorylation C S111 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Germ cell cancer Phosphorylation N S111 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Kidney renal clear cell carcinoma Phosphorylation N S111 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Melanoma Phosphorylation N S111 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Phosphorylation N S111 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Kidney renal clear cell carcinoma Phosphorylation N T116 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Phosphorylation N T116 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Kidney renal clear cell carcinoma Phosphorylation N T118 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Phosphorylation N T118 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast adenocarcinoma SUMOylation N K123 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma SUMOylation N K123 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast invasive carcinoma Methylation N K140 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast invasive carcinoma Acetylation N K144 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast invasive carcinoma Methylation N K144 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder urothelial carcinoma Acetylation N K151 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K151 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder urothelial carcinoma Methylation N K151 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N K151 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder urothelial carcinoma Acetylation N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Skin cutaneous melanoma Acetylation N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder urothelial carcinoma Methylation N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Skin cutaneous melanoma Methylation N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder urothelial carcinoma Ubiquitination N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Skin cutaneous melanoma Ubiquitination N K154 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder urothelial carcinoma Acetylation N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Skin cutaneous melanoma Acetylation N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder urothelial carcinoma Methylation N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Skin cutaneous melanoma Methylation N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder urothelial carcinoma Ubiquitination N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Skin cutaneous melanoma Ubiquitination N K156 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast invasive carcinoma Methylation N R186 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Methylation N R186 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast invasive carcinoma Phosphorylation N S193 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Glioblastoma multiforme Phosphorylation N S193 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Phosphorylation N S193 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast invasive carcinoma Acetylation N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Glioblastoma multiforme Acetylation N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Acetylation N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast invasive carcinoma Methylation N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Glioblastoma multiforme Methylation N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Methylation N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast invasive carcinoma Ubiquitination N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Glioblastoma multiforme Ubiquitination N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Uterine corpus endometrial carcinoma Ubiquitination N K195 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Glioblastoma multiforme Acetylation N K199 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Glioblastoma multiforme Methylation N K199 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Esophageal adenocarcinoma Phosphorylation N T352 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S41 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Lung squamous cell carcinoma SUMOylation N K218 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Uterine corpus endometrial carcinoma SUMOylation N K218 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Lung adenocarcinoma Methylation N K282 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Head and neck squamous cell carcinoma Phosphorylation N T354 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Uveal melanoma SUMOylation N K356 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Uveal melanoma Phosphorylation N T357 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Skin cutaneous melanoma Phosphorylation N S376 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Ovarian adenocarcinoma Phosphorylation C S451 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Lung squamous cell carcinoma Phosphorylation N S451 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Lung squamous cell carcinoma SUMOylation N K460 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Lung adenocarcinoma Phosphorylation N S489 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Lung adenocarcinoma SUMOylation N K495 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Breast invasive carcinoma Phosphorylation N Y517 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Breast invasive carcinoma Phosphorylation N S522 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Breast invasive carcinoma Phosphorylation N T524 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Bladder urothelial carcinoma Phosphorylation N T620 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Bladder urothelial carcinoma Phosphorylation N S623 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Bladder urothelial carcinoma Phosphorylation N T627 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Bladder urothelial carcinoma Phosphorylation N S692 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Uterine corpus endometrial carcinoma Phosphorylation N S692 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Bladder urothelial carcinoma Phosphorylation N S693 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Uterine corpus endometrial carcinoma Phosphorylation N S693 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Chondrosarcoma Phosphorylation N S739 Q13887 688 KLF5 BTEB2 CKLF IKLF Cervical squamous cell carcinoma and endocervical adenocarcinoma SUMOylation N K110 Q13887 688 KLF5 BTEB2 CKLF IKLF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K110 Q13887 688 KLF5 BTEB2 CKLF IKLF Bladder urothelial carcinoma Phosphorylation N S116 Q13887 688 KLF5 BTEB2 CKLF IKLF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S116 Q13887 688 KLF5 BTEB2 CKLF IKLF Breast adenocarcinoma Phosphorylation N S153 Q13887 688 KLF5 BTEB2 CKLF IKLF Bladder urothelial carcinoma SUMOylation N K162 Q13887 688 KLF5 BTEB2 CKLF IKLF Breast adenocarcinoma SUMOylation N K162 Q13887 688 KLF5 BTEB2 CKLF IKLF Lung adenocarcinoma SUMOylation N K162 Q13887 688 KLF5 BTEB2 CKLF IKLF Prostate adenocarcinoma SUMOylation N K209 Q13887 688 KLF5 BTEB2 CKLF IKLF Rectum adenocarcinoma Phosphorylation C S303 Q13887 688 KLF5 BTEB2 CKLF IKLF Colon adenocarcinoma Phosphorylation N S303 Q13887 688 KLF5 BTEB2 CKLF IKLF Colorectal cancer Phosphorylation N S303 Q13887 688 KLF5 BTEB2 CKLF IKLF Lung adenocarcinoma Phosphorylation N S303 Q13887 688 KLF5 BTEB2 CKLF IKLF Rectum adenocarcinoma Phosphorylation N S303 Q13887 688 KLF5 BTEB2 CKLF IKLF Uterine carcinosarcoma Phosphorylation N S303 Q13887 688 KLF5 BTEB2 CKLF IKLF Bladder urothelial carcinoma Phosphorylation N Y359 Q13887 688 KLF5 BTEB2 CKLF IKLF Bladder urothelial carcinoma Phosphorylation N S363 Q13887 688 KLF5 BTEB2 CKLF IKLF Pancreatic adenocarcinoma SUMOylation N K391 Q13887 688 KLF5 BTEB2 CKLF IKLF Prostate adenocarcinoma SUMOylation N K391 Q13887 688 KLF5 BTEB2 CKLF IKLF Pancreatic adenocarcinoma Ubiquitination N K391 Q13887 688 KLF5 BTEB2 CKLF IKLF Pancreatic cancer Ubiquitination N K391 Q13887 688 KLF5 BTEB2 CKLF IKLF Prostate adenocarcinoma Ubiquitination N K391 Q13887 688 KLF5 BTEB2 CKLF IKLF Stomach adenocarcinoma Phosphorylation N S441 Q13887 688 KLF5 BTEB2 CKLF IKLF Stomach adenocarcinoma Phosphorylation N S443 Q9H5K3 84197 POMK SGK196 Stomach adenocarcinoma Ubiquitination N K3 Q9H5K3 84197 POMK SGK196 Colon adenocarcinoma Ubiquitination N K93 Q9H5K3 84197 POMK SGK196 Glioblastoma multiforme Ubiquitination N K93 Q9H5K3 84197 POMK SGK196 Lung adenocarcinoma Ubiquitination N K116 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Basal-like breast cancer tumor tissue Deubiquitination U 30865895 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Pancreatic cancer tumor tissue Deubiquitination U 30352219 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Renal cell carcinoma tumor tissue Deubiquitination U 32257108 Q13887 688 KLF5 BTEB2 CKLF IKLF Breast cancer tumor tissue Deubiquitination U 31624151 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Pancreatic cancer pancreatic cancer tissues Deubiquitination U 31598398 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Breast cancer tumor tissue Phosphorylation U 36795481 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Breast cancer tumor tissue Deubiquitination U 36119839 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Cervical cancer tumor tissue Deubiquitination U 34825342 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Pancreatic cancer tumor tissue Deubiquitination U 34584067 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Gastric cancer tumor tissue Ubiquitination D 37288663 Q13887 688 KLF5 BTEB2 CKLF IKLF Basal-like breast cancer BLBC cells Ubiquitination D 33972717 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Thyroid cancer tumor tissue Ubiquitination D 33270330 P67809 4904 YBX1 NSEP1 YB1 Esophageal cancer tumor tissue Threonine phosphorylation U T89 37328464 P67809 4904 YBX1 NSEP1 YB1 Cervical cancer cervical cancer cells Serine phosphorylation D S102 33958583 P67809 4904 YBX1 NSEP1 YB1 Basal-like breast cancer tumor tissue Serine phosphorylation U S102 35022570 P67809 4904 YBX1 NSEP1 YB1 Breast cancer/tumor/carcinoma breast cancer cells Serine phosphorylation U S102 19036157 P67809 4904 YBX1 NSEP1 YB1 Hepatocellular carcinoma HCC tissues Serine phosphorylation U S102 32973139 P67809 4904 YBX1 NSEP1 YB1 Nasopharyngeal carcinoma NPC tissues and NPC cell lines Serine phosphorylation U S102 35917517 P67809 4904 YBX1 NSEP1 YB1 Colorectal cancer tumor tissue Arginine methylation U R205 32985589 P67809 4904 YBX1 NSEP1 YB1 Esophageal cancer tumor tissue Serine phosphorylation U S209 37328464 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Glioblastoma glioblastoma cells Palmitoylation P C198 35727735 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Breast cancer tumor tissue Ubiquitination P K284 29511337 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Glioblastoma tumor tissue Serine phosphorylation U S331 37822160 Q13887 688 KLF5 BTEB2 CKLF IKLF Lung cancer lung cancer tissues Dimethylation U R41 37461162 Q13887 688 KLF5 BTEB2 CKLF IKLF Basal-like breast cancer BLBC cells Arginine methylation U R57 33972717 Q13887 688 KLF5 BTEB2 CKLF IKLF Basal-like breast cancer BLBC cells Serine phosphorylation D S303 33972717 Q13887 688 KLF5 BTEB2 CKLF IKLF Prostate cancer PCa tissues Acetylation U K369 33731701;32685011 Q13887 688 KLF5 BTEB2 CKLF IKLF Prostate cancer prostate cancer cell line DU 145 Deacetylation U K369 29679567 Q9H5K3 84197 POMK SGK196 Basal-like breast cancer BC tissues N-linked glycosylation D N67 31913260 Q9H5K3 84197 POMK SGK196 Basal-like breast cancer BC tissues N-linked glycosylation D N165 31913260 Q9H5K3 84197 POMK SGK196 Basal-like breast cancer BC tissues N-linked glycosylation D N220 31913260 Q9H5K3 84197 POMK SGK196 Basal-like breast cancer BC tissues N-linked glycosylation D N235 31913260 Q13887 688 KLF5 BTEB2 CKLF IKLF Breast cancer/tumor/carcinoma Ubiquitination D 20484041 P67809 4904 YBX1 NSEP1 YB1 Diabetic cardiomyopathy Serine phosphorylation U S102 35490780 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Pancreatic cancer tumor tissue Ubiquitination D 35614040 O15162 5359 PLSCR1 Basal-like breast cancer breast tumor tissues Tyrosine phosphorylation U Y69 32292520 O15162 5359 PLSCR1 Basal-like breast cancer breast tumor tissues Tyrosine phosphorylation U Y74 32292520 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder cancer tumor tissue Acetylation N K156 27369080 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder cancer tumor tissue Lysine methylation N K156 27369080 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Bladder cancer tumor tissue Ubiquitination N K156 27369080 Q01860 5460 POU5F1 OCT3 OCT4 OTF3 Basal-like breast cancer tumor tissue Threonine phosphorylation U T343 31996785 Q9BYG0 84002 B3GNT5 Basal-like breast cancer tumor tissue N-linked glycosylation U N59 35526049 Q9BYG0 84002 B3GNT5 Basal-like breast cancer tumor tissue N-linked glycosylation U N167 35526049 Q9BYG0 84002 B3GNT5 Basal-like breast cancer tumor tissue N-linked glycosylation U N276 35526049 Q9BYG0 84002 B3GNT5 Basal-like breast cancer tumor tissue N-linked glycosylation U N335 35526049 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Glioma/adult gliomas Phosphorylation P 23404835 Q13887 688 KLF5 BTEB2 CKLF IKLF Prostate cancer/carcinoma/adenocarcinoma Ubiquitination U 15735697 Q08050 2305 FOXM1 FKHL16 HFH11 MPP2 WIN Breast cancer Threonine phosphorylation U T600 36797347